# Repurposing therapy of ibrexafungerp vulvovaginal candidiasis drugs as cancer therapeutics

**Authors:** Tedi Rustandi, Abdul Mahmud Yumassik, Fitrah Shafran Ilahi, Riza Alfian, Erna Prihandiwati, Yugo Susanto, Yudi Hardi Susilo, Maria Ulfah, Faizatun Faizatun

PMC · DOI: 10.3389/fphar.2024.1428755 · Frontiers in Pharmacology · 2024-06-27

## Full-text entities

- **Diseases:** vulvovaginal candidiasis (MESH:D002181), cancer (MESH:D009369)
- **Chemicals:** ibrexafungerp (MESH:C569338)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11236599/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11236599/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC11236599/full.md

---
Source: https://tomesphere.com/paper/PMC11236599